Cite
HARVARD Citation
Pasquier, D. et al. (n.d.). EP-1694: DW-MRI as a predictor of tumor response to hypofractionated stereotactic boost for prostate cancer. Radiotherapy and oncology. pp. S926-S927. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pasquier, D. et al. (n.d.). EP-1694: DW-MRI as a predictor of tumor response to hypofractionated stereotactic boost for prostate cancer. Radiotherapy and oncology. pp. S926-S927. [Online].